Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,706Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16Bayer Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2396561

Filing Date : 2000-12-11

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-12-11

Date Granted : 2008-10-14

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2396561

Filing Date : 2000-12-11

Strength per Unit : 15 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-12-11

Date Granted : 2008-10-14

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2396561

Filing Date : 2000-12-11

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-12-11

Date Granted : 2008-10-14

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2624310

Filing Date : 2006-09-22

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-09-22

Date Granted : 2014-01-07

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2547113

Filing Date : 2004-11-13

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-11-13

Date Granted : 2012-01-24

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2823159

Filing Date : 2006-09-22

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-09-22

Date Granted : 2014-10-21

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2624310

Filing Date : 2006-09-22

Strength per Unit : 15 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-09-22

Date Granted : 2014-01-07

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2547113

Filing Date : 2004-11-13

Strength per Unit : 15 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-11-13

Date Granted : 2012-01-24

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2823159

Filing Date : 2006-09-22

Strength per Unit : 15 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-09-22

Date Granted : 2014-10-21

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rivaroxaban

Brand Name : XARELTO

Patent Number : 2624310

Filing Date : 2006-09-22

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-09-22

Date Granted : 2014-01-07

blank